BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumar R, Harilal S, Gupta SV, Jose J, Thomas Parambi DG, Uddin MS, Shah MA, Mathew B. Exploring the new horizons of drug repurposing: A vital tool for turning hard work into smart work. Eur J Med Chem 2019;182:111602. [PMID: 31421629 DOI: 10.1016/j.ejmech.2019.111602] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Sun G, Dong D, Dong Z, Zhang Q, Fang H, Wang C, Zhang S, Wu S, Dong Y, Wan Y. Drug repositioning: A bibliometric analysis. Front Pharmacol 2022;13:974849. [DOI: 10.3389/fphar.2022.974849] [Reference Citation Analysis]
2 Zhong S, Shengyu Liu, Xin Shi, Zhang X, Li K, Liu G, Li L, Tao S, Zheng B, Sheng W, Ye Z, Xing Q, Zhai Q, Ren L, Wu Y, Bao Y. Disulfiram in glioma: Literature review of drug repurposing. Front Pharmacol 2022;13:933655. [DOI: 10.3389/fphar.2022.933655] [Reference Citation Analysis]
3 Ozleyen A, Yilmaz YB, Donmez S, Atalay HN, Antika G, Tumer TB. Looking at NSAIDs from a historical perspective and their current status in drug repurposing for cancer treatment and prevention. J Cancer Res Clin Oncol 2022. [PMID: 35876951 DOI: 10.1007/s00432-022-04187-8] [Reference Citation Analysis]
4 Tinivella A, Pinzi L, Gambacorta G, Baxendale I, Rastelli G. Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies. F1000Res 2022;11:217. [DOI: 10.12688/f1000research.109017.2] [Reference Citation Analysis]
5 Tinivella A, Pinzi L, Gambacorta G, Baxendale I, Rastelli G. Identification of potential biological targets of oxindole scaffolds via in silico repositioning strategies. F1000Res 2022;11:217. [DOI: 10.12688/f1000research.109017.1] [Reference Citation Analysis]
6 Mamta Singla, Chaudhary V, Ghosh A. Bacterial Multidrug Tolerance and Persisters: Understanding the Mechanisms, Clinical Implications, and Treatment Strategies. Antimicrobial Resistance 2022. [DOI: 10.1007/978-981-16-3120-7_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tenorio-barajas AY, Nicolas-alvarez DE, Reyes-chaparro A, Mendoza-barrera C, Magana-trejo B, Altuzar V. Comparison of performance of two virtual screening software on acetylcholinesterase protein molecular docking. 2021 18th International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE) 2021. [DOI: 10.1109/cce53527.2021.9633081] [Reference Citation Analysis]
8 Rehan M, Ahmed F, Howladar SM, Refai MY, Baeissa HM, Zughaibi TA, Kedwa KM, Jamal MS. A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm. Front Immunol 2021;12:648250. [PMID: 34248936 DOI: 10.3389/fimmu.2021.648250] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
9 Chaaban I, Hafez H, AlZaim I, Tannous C, Ragab H, Hazzaa A, Ketat S, Ghoneim A, Katary M, Abd-Alhaseeb MM, Zouein FA, Albohy A, Amer AN, El-Yazbi AF, Belal ASF. Transforming iodoquinol into broad spectrum anti-tumor leads: Repurposing to modulate redox homeostasis. Bioorg Chem 2021;113:105035. [PMID: 34091287 DOI: 10.1016/j.bioorg.2021.105035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kim J, Park SJ, Park J, Shin H, Jang YS, Woo JS, Min DH. Identification of a Direct-Acting Antiviral Agent Targeting RNA Helicase via a Graphene Oxide Nanobiosensor. ACS Appl Mater Interfaces 2021;13:25715-26. [PMID: 34036784 DOI: 10.1021/acsami.1c04641] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Wang X, Gao Y, Wang L, Yang D, Bu W, Gou L, Huang J, Duan X, Pan Y, Cao S, Gao Z, Cheng C, Feng Z, Xie J, Yao R. Troxerutin Improves Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. J Agric Food Chem 2021;69:2729-44. [PMID: 33621077 DOI: 10.1021/acs.jafc.0c06755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
12 Xiao Y, Wang SK, Zhang Y, Rostami A, Kenkare A, Casella G, Yuan ZQ, Li X. Role of extracellular vesicles in neurodegenerative diseases. Prog Neurobiol 2021;201:102022. [PMID: 33617919 DOI: 10.1016/j.pneurobio.2021.102022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
13 Mok PL, Koh AE, Farhana A, Alsrhani A, Alam MK, Suresh Kumar S. Computational drug screening against the SARS-CoV-2 Saudi Arabia isolates through a multiple-sequence alignment approach. Saudi J Biol Sci 2021;28:2502-9. [PMID: 33551661 DOI: 10.1016/j.sjbs.2021.01.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Pinho JO, Lopes J, Albino M, Reis C, Matias M, Gaspar MM. Advances in nanotechnology-related strategies against melanoma. Mitochondrial Dysfunction and Nanotherapeutics 2021. [DOI: 10.1016/b978-0-323-85666-9.00009-7] [Reference Citation Analysis]
15 Zhang L, Hu J, Xu Q, Li F, Rao G, Tao C. A semantic relationship mining method among disorders, genes, and drugs from different biomedical datasets. BMC Med Inform Decis Mak 2020;20:283. [PMID: 33317518 DOI: 10.1186/s12911-020-01274-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ingersoll MA, Malloy EA, Caster LE, Holland EM, Xu Z, Zallocchi M, Currier D, Liu H, He DZZ, Min J, Chen T, Zuo J, Teitz T. BRAF inhibition protects against hearing loss in mice. Sci Adv 2020;6:eabd0561. [PMID: 33268358 DOI: 10.1126/sciadv.abd0561] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
17 Mao X. Drug Repurposing in Neurological Diseases: Opportunities and Challenges. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications 2020. [DOI: 10.5772/intechopen.93093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Montalvo-Casimiro M, González-Barrios R, Meraz-Rodriguez MA, Juárez-González VT, Arriaga-Canon C, Herrera LA. Epidrug Repurposing: Discovering New Faces of Old Acquaintances in Cancer Therapy. Front Oncol 2020;10:605386. [PMID: 33312959 DOI: 10.3389/fonc.2020.605386] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
19 Uddin MS, Al Mamun A, Kabir MT, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM. Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets. Mol Neurobiol 2021;58:281-303. [PMID: 32935230 DOI: 10.1007/s12035-020-02116-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
20 Silva LR, da Silva Santos-Júnior PF, de Andrade Brandão J, Anderson L, Bassi ÊJ, Xavier de Araújo-Júnior J, Cardoso SH, da Silva-Júnior EF. Druggable targets from coronaviruses for designing new antiviral drugs. Bioorg Med Chem 2020;28:115745. [PMID: 33007557 DOI: 10.1016/j.bmc.2020.115745] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
21 Advani D, Gupta R, Tripathi R, Sharma S, Ambasta RK, Kumar P. Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach. Neurochem Int 2020;140:104841. [PMID: 32853752 DOI: 10.1016/j.neuint.2020.104841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mazzolari A, Gervasoni S, Pedretti A, Fumagalli L, Matucci R, Vistoli G. Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays. Int J Mol Sci 2020;21:E5961. [PMID: 32825082 DOI: 10.3390/ijms21175961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
23 Harilal S, Jose J, Parambi DGT, Kumar R, Unnikrishnan MK, Uddin MS, Mathew GE, Pratap R, Marathakam A, Mathew B. Revisiting the blood-brain barrier: A hard nut to crack in the transportation of drug molecules. Brain Res Bull 2020;160:121-40. [PMID: 32315731 DOI: 10.1016/j.brainresbull.2020.03.018] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 23.5] [Reference Citation Analysis]
24 Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, Sampani K, Steliou K, Vavvas DG, Zamboni RJ, Kodukula K, Chen X. Klotho Pathways, Myelination Disorders, Neurodegenerative Diseases, and Epigenetic Drugs. Biores Open Access 2020;9:94-105. [PMID: 32257625 DOI: 10.1089/biores.2020.0004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Barrett JE, Page C, Michel MC. Perspectives of Pharmacology over the Past 100 Years. Handb Exp Pharmacol 2019;260:3-16. [PMID: 31823070 DOI: 10.1007/164_2019_334] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]